Barrier Reverse Convertible

Symbol: ABGMSQ
ISIN: CH1305627197
Issuer:
Swissquote Bank SA
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 101.32
Diff. absolute / % 0.13 +0.13%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Barrier Reverse Convertible
ISIN CH1305627197
Valor 130562719
Symbol ABGMSQ
Quotation in percent Yes
Coupon p.a. 10.42%
Coupon Premium 6.88%
Coupon Yield 3.54%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency Euro
First Trading Date 11/03/2024
Date of maturity 11/03/2025
Last trading day 03/03/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Swissquote Bank SA

Key data

Ask Price (basis for calculation) 102.2600
Maximum yield 5.43%
Maximum yield p.a. 8.33%
Sideways yield 5.43%
Sideways yield p.a. 8.33%

market maker quality Date: 15/07/2024

Average Spread 0.80%
Last Best Bid Price 101.32 %
Last Best Ask Price 102.13 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 253,459 EUR
Average Sell Value 255,484 EUR
Spreads Availability Ratio 100.00%
Quote Availability 100.00%

Underlyings

Name Eli Lilly & Co. Johnson & Johnson Novo Nordisk AS (B)
ISIN US5324571083 US4781601046 DK0062498333
Price 830.00 CHF 138.19 EUR 129.37 EUR
Date 03/07/24 09:00 16/07/24 19:59 16/07/24 19:58
Cap 782.12 USD 162.12 USD 850.90 DKK
Distance to Cap 166.67 -11.37 122.4
Distance to Cap in % 17.57% -7.54% 12.58%
Is Cap Level reached No No No
Barrier 461.451 USD 95.6508 USD 502.031 DKK
Distance to Barrier 487.339 55.0992 471.269
Distance to Barrier in % 51.36% 36.55% 48.42%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.